Laws & Regulations

Federal Court Overturns FDA Regulation on Lab Developed Tests
Regulatory & Compliance Federal Court Overturns FDA Regulation on Lab Developed Tests

In a landmark ruling, a Texas federal court recently overturned the Food and Drug Administration’s (FDA) regulation of laboratory-developed tests (LDTs) as medical devices. This decision, made by Judge Sean Jordan of the U.S. District Court for the Eastern District of Texas, vacates the FDA’s final

Are Trump's Public Health Cuts Threatening State Emergencies?
Regulatory & Compliance Are Trump's Public Health Cuts Threatening State Emergencies?

The recent lawsuit initiated by a coalition of 23 states and Washington, D.C., against the U.S. Department of Health and Human Services (HHS) is raising critical concerns about the potential impact of over $11 billion cuts to public health funding. These cuts, originally allocated during the

HHS Undergoes Massive Restructuring, Slashing 10,000 Jobs
Regulatory & Compliance HHS Undergoes Massive Restructuring, Slashing 10,000 Jobs

The U.S. Department of Health and Human Services (HHS) unveiled a massive restructuring plan early one morning, announcing the elimination of 10,000 full-time employees, reducing its number of divisions from 28 to 15, and halving the number of regional offices. This extensive overhaul is intended

How Will HHS Layoffs and Reorganization Impact U.S. Healthcare?
Regulatory & Compliance How Will HHS Layoffs and Reorganization Impact U.S. Healthcare?

The Department of Health and Human Services (HHS) employees faced significant turmoil following the Trump administration's unexpected announcement of massive layoffs and restructuring. The HHS plans to terminate 10,000 full-time employees, reduce 28 divisions to 15, and halve the number of regional

Will Medicaid Cuts Harm Vulnerable Americans and Hit State Economies?
Regulatory & Compliance Will Medicaid Cuts Harm Vulnerable Americans and Hit State Economies?

The discussion surrounding potential Medicaid funding cuts has sparked vigorous debate, with hundreds of advocacy groups urging Senate Majority Leader John Thune to reconsider the proposed reductions. The implications of these cuts extend far beyond budgetary concerns, impacting millions of

Is J&J's $55 Billion U.S. Investment Changing Pharmaceutical Manufacturing?
Regulatory & Compliance Is J&J's $55 Billion U.S. Investment Changing Pharmaceutical Manufacturing?

Johnson & Johnson’s commitment to investing $55 billion in U.S. manufacturing, research, and development over the next four years marks a significant expansion for the renowned pharmaceutical company. Announced by CEO Joaquin Duato on March 21, this ambitious initiative is intended to bolster the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later